標普生物科技ETF-SPDR

169.04
Open
166.18
Market Cap
11.76B+
High
169.89
Low
165.79
Close
169.10
Volume
9.90M+
P/E Ratio
0.00
Div/Yield
0.00%

About 標普生物科技ETF-SPDR

SPDR Series Trust - SPDR S&P Biotech ETF 是由 State Street Global Advisors, Inc. 推出的交易所交易基金。該基金由 SSGA Funds Management, Inc. 管理,投資於美國的公共股票市場。它投資於醫療保健、製藥、生物技術和生命科學領域的公司股票。該基金投資於多元化市值公司的成長型和價值型股票。它試圖通過使用代表性抽樣技術來追踪標準普爾生物技術精選行業指數的表現。 SPDR Series Trust - SPDR S&P Biotech ETF 成立於 2006 年 1 月 31 日,註冊地在美國。

如何購買 標普生物科技ETF-SPDR (XBI)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 XBI

購買 XBI

透過 RockFlow App 或網頁端搜尋 XBI,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

社交媒體

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.